Literature DB >> 30673135

Are all chromosome microarrays the same? What clinicians need to know.

Brynn Levy1, Rachel D Burnside2.   

Abstract

Microarray testing is the recommended first-tier diagnostic test for women who undergo invasive prenatal diagnostic procedures. It is well-established that microarray analysis provides information regarding copy number for changes (or copy number variants, CNVs) that may be below the resolution level of standard chromosome analysis, and that such CNVs are not related to maternal age. What may not be appreciated by ordering providers, however, are the technical differences among laboratories with respect to the established laboratory cutoff values for reporting, the definition of targeted versus nontargeted regions, and how these differences may affect the interpretation and reporting of findings which, in turn, affects counseling and possible follow-up testing of family members. Here, we provide a detailed explanation of these technical factors and clarify how they practically impact diagnostic results.
© 2019 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2019        PMID: 30673135     DOI: 10.1002/pd.5422

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  5 in total

Review 1.  How to evaluate for immunodeficiency in patients with autoimmune cytopenias: laboratory evaluation for the diagnosis of inborn errors of immunity associated with immune dysregulation.

Authors:  Roshini S Abraham
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2020-12-04

2.  Array-comparative Genomic Hybridization Results in Clinically Affected Cases with Apparently Balanced Chromosomal Rearrangements.

Authors:  N B Satkin; B Karaman; S Ergin; H Kayserili; I H Kalelioglu; R Has; A Yuksel; S Basaran
Journal:  Balkan J Med Genet       Date:  2021-03-23       Impact factor: 0.519

Review 3.  DNA Methylation Episignatures in Neurodevelopmental Disorders Associated with Large Structural Copy Number Variants: Clinical Implications.

Authors:  Kathleen Rooney; Bekim Sadikovic
Journal:  Int J Mol Sci       Date:  2022-07-16       Impact factor: 6.208

Review 4.  Chances and Challenges of New Genetic Screening Technologies (NIPT) in Prenatal Medicine from a Clinical Perspective: A Narrative Review.

Authors:  Ivonne Bedei; Aline Wolter; Axel Weber; Fabrizio Signore; Roland Axt-Fliedner
Journal:  Genes (Basel)       Date:  2021-03-29       Impact factor: 4.096

5.  Optical Genome Mapping in Routine Human Genetic Diagnostics-Its Advantages and Limitations.

Authors:  Paul Dremsek; Thomas Schwarz; Beatrix Weil; Alina Malashka; Franco Laccone; Jürgen Neesen
Journal:  Genes (Basel)       Date:  2021-12-08       Impact factor: 4.096

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.